Cytosorbents CorporationCTSONASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-55.65%
↓ 361% below average
Average (9y)
21.33%
Historical baseline
Range
High:90.72%
Low:-55.65%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | -55.65% |
| 2023 | 3.15% |
| 2022 | -7.70% |
| 2021 | 85.92% |
| 2020 | -27.14% |
| 2019 | 56.57% |
| 2018 | 90.72% |
| 2017 | -15.35% |
| 2016 | 23.57% |
| 2015 | 59.17% |